The frequency of human papillomavirus infection in Polish patients with vulvar squamous cell carcinoma

International Journal of Gynecological Cancer

Volumn 20, Issue 3, 2010, Pages 434-437

  Kowalewska, Magdalena ^a   Szkoda, Marek Tomasz ^b   Radziszewski, Jakub ^a   Ptaszynski, Konrad ^a   Bidzinski, Mariusz ^a   Siedlecki, Janusz Aleksander ^a  

^a INSTITUTE OF ONCOLOGY   (Poland)

^b NATIONAL INSTITUTE OF HYGIENE   (Poland)

Author keywords

HPV; Lymph nodes; Vulvar cancer

Indexed keywords

VIRUS DNA;

ADULT; AGED; ARTICLE; CANCER STAGING; CANCER TISSUE; CLINICAL ARTICLE; CONTROLLED STUDY; DNA VIRUS INFECTION; FEMALE; GENOTYPE; HISTOPATHOLOGY; HUMAN; HUMAN PAPILLOMAVIRUS TYPE 16; HUMAN PAPILLOMAVIRUS TYPE 58; HUMAN PAPILLOMAVIRUS TYPE 6; HUMAN TISSUE; INFECTION RATE; LYMPH NODE METASTASIS; POLAND; PRIORITY JOURNAL; SQUAMOUS CELL CARCINOMA; VIRUS DETECTION; VIRUS LOAD; VULVA CARCINOMA; WART VIRUS;

ADULT; AGED; AGED, 80 AND OVER; CARCINOMA, SQUAMOUS CELL; DNA, VIRAL; FEMALE; HUMANS; INCIDENCE; MIDDLE AGED; NEOPLASM STAGING; PAPILLOMAVIRIDAE; PAPILLOMAVIRUS INFECTIONS; POLAND; PROGNOSIS; VULVAR NEOPLASMS;

EID: 77952160704     PISSN: 1048891X     EISSN: None     Source Type: Journal    
DOI: 10.1111/IGC.0b013e3181d320f1     Document Type: Article

References (26)

1. Parkin DM, Bray F. Chapter 2: the burden of HPV-related cancers. Vaccine. 2006;24: S11-S25.
2. Ghurani GB, Penalver MA. An update on vulvar cancer. Am J Obstet Gynecol. 2001;185:294-299.
3. National Cancer Registry. Available at: http://epid.coi.waw.pl/krn/.
4. Walboomers JM, Jacobs MV, Manos MM, et al. Human papillomavirus is a necessary cause of invasive cervical cancer worldwide. J Pathol. 1999;189:12-19.
5. Parkin DM. The global health burden of infection-associated cancers in the year 2002. Int J Cancer. 2006;118:3030-3044.
6. IARC. IARC monographs on the evaluation of carcinogenic risks to humans. Human papillomaviruses. Lyon: IARC; 2005:90.
7. Hampl M, Sarajuuri H, Wentzensen N, et al. Effect of human papillomavirus vaccines on vulvar, vaginal, and anal intraepithelial lesions and vulvar cancer. Obstet Gynecol. 2006;108:1361-1368.
8. Sutton BC, Allen RA, Moore WE, et al. Distribution of human papillomavirus genotypes in invasive squamous carcinoma of the vulva. Mod Pathol. 2008;21:345-354.
9. van de Nieuwenhof HP, van der Avoort IA, de Hullu JA. Review of squamous premalignant vulvar lesions. Crit Rev Oncol Hematol. 2008; ahead of print.
10. Kowalewska M, Radziszewski J, Kulik J, et al. Detection of carbonic anhydrase 9-expressing tumor cells in the lymph nodes of vulvar carcinoma patients by RT-PCR. Int J Cancer. 2005;116:957-962.
11. Muñoz N, Castellsagué X, de González AB, et al. Chapter 1: HPV in the etiology of human cancer. Vaccine. 2006;24S3: S1-S10.
12. Bardin A, Vaccarella S, Clifford GM, et al. Human papillomavirus infection in women with and without cervical cancer in Warsaw, Poland. Eur J Cancer. 2008;44:557-564.
13. Clifford GM, Gallus S, Herrero R, et al. Worldwide distribution of human papillomavirus types in cytologically normal women in the International Agency for Research on Cancer HPV prevalence surveys: a pooled analysis. Lancet. 2005;366:991-998.
14. Franceschi S, Herrero R, Clifford GM, et al. Variations in the age-specific curves of human papillomavirus prevalence in women worldwide. Int J Cancer. 2006;119:2677-2684.
15. Lrding U, Kringsholm B, Andreasson B, et al. Human papillomavirus in vulvar squamous-cell carcinoma and in normal vulvar tissues: a search for a possible impact of HPV on vulvar cancer prognosis. Int J Cancer. 1993;55:394-396.
16. Andersen WA, Franquemont DW, Williams J, et al. Vulvar squamous cell carcinoma and papillomaviruses: two separate entities? Am J Obstet Gynecol. 1991;165:329-335
17. Bloss JD, Liao SY, Wilczynski SP, et al. Clinical and histologic features of vulvar carcinomas analyzed for human papillomavirus status: evidence that squamous cell carcinoma of the vulva has more than one etiology. Hum Pathol. 1991;22:711-718.
18. Toki T, Kurman RJ, Park JS, et al. Probable nonpapillomavirus etiology of squamous cell carcinoma of the vulva in older women: a clinicopathologic study using in situ hybridization and polymerase chain reaction. Int J Gynecol Pathol. 1991;10:107-125.
19. Skapa P, Zamecnik J, Hamsikova E, et al. Human papillomavirus (HPV) profiles of vulvar lesions: possible implications for the classification of vulvar squamous cell carcinoma precursors and for the efficacy of prophylactic HPV vaccination. Am J Surg Pathol. 2007;31:1834-1843.
20. Paavonen J, Jenkins D, Bosch FX, et al. Efficacy of a prophylactic adjuvanted bivalent L1 virus-like-particle vaccine against infection with human papillomavirus types 16 and 18 in young women: an interim analysis of a phase III double-blind, randomised controlled trial. Lancet. 2007;369:2161-2170.
21. Pinto AP, Schlecht NF, Pintos J, et al. Prognostic significance of lymph node variables and human papillomavirus DNA in invasive vulvar carcinoma. Gynecol Oncol. 2004;92:856-865.
22. Lee YS, Rhim CC, Lee HN, et al. HPV status in sentinel nodes might be a prognostic factor in cervical cancer. Gynecol Oncol. 2007;105:351-357.
23. Lukaszuk K, Liss J, Gulczynski J, et al. Predictive value of HPV DNA in lymph nodes in surgically treated cervical carcinoma patients-a prospective study. Gynecol Oncol. 2007;104:721-726.
24. Ansink AC, Krul MR, De Weger RA, et al. Human papillomavirus, lichen sclerosus, and squamous cell carcinoma of the vulva: detection and prognostic significance. Gynecol Oncol. 1994;52:180-184.
25. Monk BJ, Burger RA, Lin F, et al. Prognostic significance of human papillomavirus DNA in vulvar carcinoma. Obstet Gynecol. 1995;85:709-715.
26. Knopp S, Nesland JM, Tropé C, et al. p14ARF, a prognostic predictor in HPV-negative vulvar carcinoma. Am J Clin Pathol. 2006;126:266-276.